IgG, IgA and IgE autoantibodies against the ectodomain of BP180 in patients with bullous and cicatricial pemphigoid and linear IgA bullous dermatosis

Background Bullous pemphigoid (BP), linear IgA bullous dermatosis (LABD) and cicatricial pemphigoid (CP) are clinically distinct autoimmune bullous skin diseases characterized by autoantibodies against components of the epidermal basement membrane. Like most patients with BP, a significant subgroup...

Full description

Saved in:
Bibliographic Details
Published in:British journal of dermatology (1951) 2000-08, Vol.143 (2), p.349-355
Main Authors: Christophoridis, S., Büdinger, L., Borradori, L., Hunziker, T., Merk, H.F., Hertl, M.
Format: Article
Language:English
Subjects:
Adult
Autoantibodies - blood
Autoantigens - immunology
Autoimmune Diseases - immunology
autoimmunity
B lymphocytes
Biological and medical sciences
BP180
Bullous diseases of the skin
bullous pemphigoid
cicatricial pemphigoid
Collagen Type XVII
Dermatology
epitope
hemidesmosomes
Humans
Immunoblotting
Immunoglobulin A - blood
Immunoglobulin E - blood
Immunoglobulin G - blood
immunoglobulin subtypes
linear IgA bullous dermatosis
Medical sciences
Non-Fibrillar Collagens
Pemphigoid, Benign Mucous Membrane - immunology
Pemphigoid, Bullous - immunology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background Bullous pemphigoid (BP), linear IgA bullous dermatosis (LABD) and cicatricial pemphigoid (CP) are clinically distinct autoimmune bullous skin diseases characterized by autoantibodies against components of the epidermal basement membrane. Like most patients with BP, a significant subgroup of patients with CP has circulating IgG specific for BP180, a transmembraneous protein of hemidesmosomes. Moreover, sera of patients with LABD contain IgA autoantibodies reactive with a 97/120‐kDa protein, LABD antigen 1, which is highly homologous to the extracellular portion of BP180. Objectives We aimed to determine whether, in these diseases, autoantibody reactivity to BP180 is restricted to distinct immunoglobulin subtypes. Methods Utilizing a baculovirus‐encoded form of the ectodomain of BP180, sera from patients with BP (n = 10), CP (n = 9), LABD (n = 10) and normal human control sera (n = 10) were analysed by immunoblot for IgG, IgA and IgE reactivity against BP180.  Results All of 10 BP sera displayed IgG, IgA and IgE reactivity with BP180. Six and seven of nine CP sera, respectively, contained IgG and IgA autoantibodies reactive with BP180, but none of nine sera contained BP180‐specific IgE. Nine of 10 LABD sera contained IgA, and six of 10 IgG, which was reactive with BP180, but none of 10 sera showed IgE reactivity to BP180.  Conclusions The presence of IgG and IgA autoantibody responses to BP180 in patients with three clinically distinct autoimmune bullous diseases indicates that an autoimmune response to the same distinct adhesion protein may lead to different clinical manifestations. It is therefore conceivable that variable epitopes of BP180 are targeted by the different autoantibody isotypes, resulting in the distinct clinical pictures.
ISSN:0007-0963
1365-2133
DOI:10.1046/j.1365-2133.2000.03661.x